To include your compound in the COVID-19 Resource Center, submit it here.

Provigil modafinil: Phase III data; marketed to treat excessive daytime sleepiness in narcolepsy

In a Phase III trial of Provigil modafinil C-IV in 209 SWSD patients, Provigil improved

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE